Latest Blog Posts Tagged "FDA-approved drugs"
March 22, 2017
The U.S. Food and Drug Administration (FDA) has approved a new drug called Xadago (safinamide) from Newron Pharmaceuticals for people with Parkinson's disease (PD) who are taking levodopa.
March 10, 2017
Generic medications are substitutes for brand name drugs. They're typically less expensive, widely available and commonly prescribed.
May 31, 2016
Nuplazid, a drug indicated for the treatment of Parkinson's disease psychosis, is now available for prescription.
May 18, 2016
The FDA recently published a report detailing the impact of Parkinson's disease (PD) on patients and their loved ones.
April 29, 2016
The Food and Drug Administration has approved Nuplazid to treat Parkinson's psychosis.
May 06, 2015
Dr. Rachel Dolhun tells Practical Neurology about recently approved levodopa formulations that may help avoid wearing off and dyskinesia.
March 29, 2015
Rytary, an extended-release formuation of levodopa/carbidopa, will soon be available for prescription. The treatment requires more pills but comes with less dyskinesia.
January 12, 2015
Today pharmaceutical company AbbVie announced it has obtained approval for Duopa, its gel formulation of levodopa/carbidopa infused directly into the small intestine.
January 08, 2015
Today MJFF-awardee Impax Pharmaceuticals announced that the FDA approved RYTARY, an extended-release oral capsule formulation of levodopa-carbidopa, for the treatment of Parkinson's.
September 15, 2014
Northera, a drug approved earlier this year for people with Parkinson's who experience orthostatic hypotension — a sudden drop in blood pressure when standing up — is now available for prescription....